Clinical Trials in Foshan, Guangdong
57 recruiting
Showing 1–20 of 46 trials
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled492 locationsNCT07517263
Recruiting
Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Marginal Zone LymphomaRelapsed/Refractory Follicular Lymphoma
BeiGene780 enrolled277 locationsNCT05100862
Recruiting
Phase 2Phase 3
Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia
Radiation Induced Lung InjuryImmune-related Pneumonia
Beijing Continent Pharmaceutical Co, Ltd.298 enrolled36 locationsNCT07388680
Recruiting
Not Applicable
Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis
Rheumatoid Arthritis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University130 enrolled5 locationsNCT06301373
Recruiting
Phase 3
A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Taizhou Hanzhong biomedical co. LTD190 enrolled63 locationsNCT05652894
Recruiting
Phase 2
Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled Study
Endonasal SurgerySellar TumorCsf Leakage
Nanfang Hospital, Southern Medical University126 enrolled8 locationsNCT07539792
Recruiting
Phase 2
A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia
Anemia
Bristol-Myers Squibb189 enrolled36 locationsNCT05664737
Recruiting
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA
Hepatocellular Carcinoma Resectable
Zhujiang Hospital255 enrolled7 locationsNCT06157060
Recruiting
Phase 3
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
Nasopharyngeal Carcinoma
Sun Yat-sen University593 enrolled26 locationsNCT06239727
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Phase 2
Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps
Chronic rhinosinusitis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.120 enrolled28 locationsNCT06439381
Recruiting
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease
Major Cardiovascular EventEstablished Atherosclerotic Cardiovascular Disease
Amgen7,000 enrolled90 locationsNCT06295679
Recruiting
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
EGFR Mutant Advanced Non-small Cell Lung CancerCentral Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd.800 enrolled34 locationsNCT07143045
Recruiting
Not Applicable
Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes
healthy pregnant women
a2 Milk Company Ltd.100 enrolled6 locationsNCT06980376
Recruiting
Phase 1
A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Excyte Biopharma Ltd70 enrolled12 locationsNCT06574568
Recruiting
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
Chronic Kidney Disease
Guangdong Provincial People's Hospital90,000 enrolled8 locationsNCT05188885
Recruiting
Early Phase 1
JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
Shenzhen Genocury Biotech Co., Ltd.9 enrolled1 locationNCT07336823
Recruiting
Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
Lung CancerPulmonary Nodules, SolitaryPulmonary Nodules, Multiple
ChromX Health3,000 enrolled15 locationsNCT06518655
Recruiting
Phase 2
Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Sun Yat-sen University198 enrolled3 locationsNCT05959356
Recruiting
CHina Adrenal Venous saMPling InvestigatiON
AdrenalectomyHyperaldosteronismAdrenal Venous Sampling
Chinese Academy of Medical Sciences, Fuwai Hospital5,000 enrolled76 locationsNCT07252284